Copyright
©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1395-1406
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1395
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1395
Figure 3 Comparison between mesenchymal-epithelial transition factor fluorescence in situ hybridization and immunohistochemistry results.
A: The c-mesenchymal-epithelial transition factor (MET) immunohistochemistry (IHC) status in MET fluorescence in situ hybridization positive and negative cases; B: The scatter plot representations of MET gene copy number in different c-MET IHC groups; C: The scatter plot representations of MET/CEP7 ratios in different c-MET IHC groups. MET: Mesenchymal-epithelial transition factor; GCN: Gene copy number; IHC: Immunohistochemistry.
- Citation: Yu QX, Fu PY, Zhang C, Li L, Huang WT. Mesenchymal-epithelial transition factor amplification correlates with adverse pathological features and poor clinical outcome in colorectal cancer. World J Gastrointest Surg 2024; 16(5): 1395-1406
- URL: https://www.wjgnet.com/1948-9366/full/v16/i5/1395.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i5.1395